MIRA INFORM REPORT

 

 

Report Date :

16.08.2014

 

IDENTIFICATION DETAILS

 

Name :

ALEMBIC PHARMACEUTICALS LIMITED (w.e.f. 12.03.2011)

 

 

Formerly Known As :

ALEMBIC PHARMA LIMITED

 

 

Registered Office :

Alembic Road, Vadodara – 390002, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

16.06.2010

 

 

Com. Reg. No.:

04-061123

 

 

Capital Investment / Paid-up Capital :

Rs.377.032 Millions

 

 

CIN No.:

[Company Identification No.]

L24230GJ2010PLC061123

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BRDA03515B

 

 

PAN No.:

[Permanent Account No.]

AAICA5591M

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on The Stock Exchanges.

 

 

Line of Business :

Manufacturer of Pharmaceutical Products.

 

 

No. of Employees :

6300 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (64)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 25000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Not Available

 

 

Comments :

Subject is a well-established company having fine track record.

 

The rating reflects company’s healthy financial risk profile marked by adequate liquidity position and decent profitability levels of the company.

 

Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitment.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

As per the latest IMF study, the total weigh of emerging markets in the GDP of the world on a purchasing power parity basis has seen a sizeable shift. It highlights how as against 51 % in 2005, the emerging economies now account for close to 56 % of the global purchasing power GDP as per the latest survey. And with the emerging economies growing at a faster rate than their developed counterparts, there are every possibility that the their share goes up further in the coming years.  China may surpass the US over the next few years.

 

Politics and economics are very intricately connected. They tend to influence each other in ways that could be very complex and far-reaching. The prospects of the India’s economy have been seriously compromised due to political corruption. High inflation, poor standard of living are to a great extent a result of rampant corruption in the country. China on the other hand, seems to be facing diametrically opposite challenge. American hedge fund manager Jim Chanos has been keenly following the political and economic development in the dragon economy and has figured out something that is quite worrying. He is of the view that the Chinese economy could be heading toward trouble on account of new Chinese President Xi Jingping’s very aggressive anti-corruption drive. Chanos believes tat many things such as apartment sales, luxury products, etc. were largely bought with dirty money. And it is now beginning to impact consumption. This may indeed be bad news for an economy that is struggling to transition from an investment-driven export-oriented economy to a domestic consumption-driven economy.

 

A study published by Firstpost has revealed that asset classes like real estate and equities were the biggest beneficiaries of the liberalization policies.  A firm called Ciane Analytics studied returns from assets including equities, gold, fixed deposits, G-Secs and real estate since 1991. Real estate outperformed every other asset classes during the 23-year period with an annualized return of 20 % ! Equities came in second with annualized return of 15.5 % ! However, while these returns may seem mouthwatering, the fact is that the return from equities adjusted for inflation came down to just 7.1 %.

 

Some brief news are as under

. R-Power to buy Jaypee’s hydro assets

. Investors await justice in NSEL case

. India seeks MFN status from Pakistan ahead of meeting

. Ukrain’s clashes with rebels hinder MH17 crash investigation

. India exploring merger of state-owned hydro PSUs

..Higher costs weigh down profit growth to slowest in 9 quarters

..Wal-Mart to expand wholesale business in India

. GMR group moves to strengthen balance sheet

. Central Bank to sell 4 % stake to Life Insurance Corporation

. Tata Chemicals plans to raise up to Rs 10000 mn.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating: AA

Rating Explanation

Have degree of safety and carry very low credit risk.

Date

05.06.2014

 

Rating Agency Name

CRISIL

Rating

Short term rating: A1+

Rating Explanation

Have very strong degree of safety and carry lowest credit risk.

Date

05.06.2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DENIED

 

Management Non Co-operative (91-265-2280880)

 

 

LOCATIONS

 

Registered Office / Factory 1 :

Alembic Road, Vadodara-390002, Gujarat, India

Tel. No.:

91-265-2280550/2280880

Fax No.:

91-265-2281508/22847283053333/300

E-Mail :

infoal@alembic.co.in

apl.investors@alembic.co.in

chirag.shukla@alembic.co.in

Website :

www.alembic-india.com

 

 

Marketing Office:

2nd Floor , Prime Corporate Park, Behind ITC Grand Maratha Sheraton, Sahar Road, Andheri (E), Mumbai - 400099, Maharashtra, India

Tel. No.:

91-22-30611698

Fax No.:

91-22-30611682

 

 

Factory 2 :

Plot No.21/22, EPIP-Phase-I, Jhamajri, Baddi, Tehsil – Nalagarh, Solan – 173205, Himachal Pradesh, India

 

 

Factory 3 :

Village Karakhadi, Taluka Padra, District Vadodara, Gujarat, India

 

 

Factory 4 :

Panelav, Tal. Halol, District Panchmahal-389350, Gujarat, India

 

 

DIRECTORS

 

AS ON 31.03.2014

 

Name :

Mr. Chirayu Ramanbhai Amin

Designation :

Chairman and Managing Director

Address :

F 10/195, Race Course Circle, Gorti Road, Vadodara – 390007, Gujarat, India 

Date of Birth/Age :

04.12.1946

 

 

Name :

Mr. Krishnapuram Ramanathan

Designation :

Director

Address :

Srinidhi Bunglow, No. 1, Octroi Naka, Gorti Road, Vadodara – 390007, Gujarat, India

Date of Birth/Age :

15.05.1939

 

 

Name :

Mr. Rajkumar Shreeram Baheti

Designation :

Director and President-Finance

Address :

Flat No.402, Samprat Residency, 52, Alkapuri Society, Alkapuri, Vadodara – 390007, Gujarat, India

Date of Birth/Age :

24.10.1959

 

 

Name :

Mr. Pranav Natverlal Parikh

Designation :

Director

Address :

18 A, Manek, LD Ruparel Marg, Malbar hill, Mumbai – 400006, Maharashtra, India  

Date of Birth/Age :

18.02.1943

 

 

Name :

Mr. Paresh Saraiya

Designation :

Director

 

 

Name :

Mr. Pranav Amin

Designation :

Director and President-International Business

 

 

Name :

Mr. Milin Mehta

Designation :

Director

 

 

Name :

Mr. Shaunak Amin

Designation :

Director & President-Branded Formulations Business (w.e.f. 2nd May, 2013)

 

KEY EXECUTIVES

 

Name :

Mr. Rajkumar Shreeram Baheti

Designation :

Company Secretary

 

 

MAJOR SHAREHOLDERS

 

AS ON 31.03.2014

 

Category of Shareholder

Total No. of Shares

% of Shares

(A) Shareholding of Promoter and Promoter Group

 

 

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

13402430

7.11

http://www.bseindia.com/include/images/clear.gifBodies Corporate

126336190

67.02

http://www.bseindia.com/include/images/clear.gifSub Total

139738620

74.13

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

139738620

74.13

(B) Public Shareholding

 

 

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifMutual Funds / UTI

2240232

1.19

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

1207039

0.64

http://www.bseindia.com/include/images/clear.gifForeign Institutional Investors

16633560

8.82

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

3600

0.00

http://www.bseindia.com/include/images/clear.gifOverseas Corporate Bodies

750

0.00

http://www.bseindia.com/include/images/clear.gifEmployee Welfare Fund

2850

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

20084431

10.65

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

1712256

0.91

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs.0.100 Million

21218663

11.26

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs.0.100 Million

4949984

2.63

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

811960

0.43

http://www.bseindia.com/include/images/clear.gifClearing Members

267376

0.14

http://www.bseindia.com/include/images/clear.gifTrusts

16380

0.01

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

528204

0.28

http://www.bseindia.com/include/images/clear.gifSub Total

28692863

15.22

Total Public shareholding (B)

48777294

25.87

Total (A)+(B)

188515914

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

0

0.00

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

Total (A)+(B)+(C)

188515914

0.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Products.

 

 

GENERAL INFORMATION

 

No. of Employees :

6300 (Approximately)

 

 

Bankers :

·         Axis Bank Limited

·         Bank of Baroda

·         HDFC Bank Limited

·         IDBI Bank Limited

·         Standard Chartered Bank

·         The Royal Bank of Scotland N.V

 

 

Facilities :

SECURED LOANS

31.03.2014

Rs. In Millions

31.03.2013

Rs. In Millions

Long Term Borrowings

 

 

Term loans

 

 

Foreign Currency loan from Banks - @ Coupon of LIBOR plus 1.50% p.a. plus proportionate front end fees Secured against first hypothecation charge on all movable plant and machinery ranking pari passu with other lenders Redeemable in 15 equal quarterly installments of USD 1 MN from May-13)

419.470

597.080

 

 

 

Short Term Borrowings

 

 

Working Capital facilities

(Secured against first hypothecation on Stocks and Book Debts ranking pari passu - @ varying Coupon repayable on demand)

54.380

104.065

 

 

 

Total

473.850

701.145

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

K.S. Aiyar and Company

Chartered Accountants

Address :

Laxmi Estate No. F-07/08, Shakti Mills Lane, Off Dr. E. Moses Road, Mahalaxmi, Mumbai-400011, Maharashtra, India

Tel No.:

91-22-24932502/66551770

Fax No.:

91-22-66551774

Email:

mail@ksaiyar.com

Website:

www.ksaiyar.com

 

 

Subsidiary and Fellow Subsidiary :

·         Alembic Global Holding SA (Subsidiary of Alembic Pharmaceuticals Limited)

·         Alembic Pharmaceuticals Australia Pty Ltd (Subsidiary of Alembic Global Holding SA)

·         Alembic Pharmaceuticals Europe Limited (Subsidiary of Alembic Global Holding SA)

·         Alnova Pharmaceuticals SA (Subsidiary of Alembic Global Holding SA)

·         Alembic Pharmaceuticals Inc. (Subsidiary of Alembic Global Holding SA)

·         Alembic Pharmaceuticals Canada Ltd (Subsidiary of Alembic Global Holding SA)

 

 

Associate Companies :

·         Alembic Limited

·         Whitefield Chemtech Private Limited

·         Nirayu Private Limited

·         Quick Flight Limited

·         Shreno Limited

·         Paushak Limited

·         Sierra Investments Limited

·         Viramya Packlight Limited

·         Incozen Therapeutics Private Limited

·         Rhizen Pharmaceuticals SA

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2014

 

A)      Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

200000000

Equity Shares

Rs.2/- each

Rs.400.000 Millions

 

 

 

 

 

B)      Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

188515914

Equity Shares

Rs.2/- each

Rs.377.032 Millions

 

 

 

 

 

Out of above 13,35,15,914 equity shares of Rs.2/- each were issued to the shareholders of Alembic Limited as per the Scheme of Arrangement and without payment being received in cash

 

 

C)      Reconciliation of the number of shares outstanding at the beginning and at the end of the reporting period:

 

Particulars

As on 31.03.2014

No. of Shares

Rs. in Millions

At the beginning of the period

18,85,15,914

377.032

Issued during the period

--

--

Outstanding at the end of the period

118,85,15,914

377.032

 

 

D)      The rights, preferences and restrictions including restrictions on the distribution of dividends and the repayment of capital The company is having only one class of shares i.e. Equity carrying a nominal value of H 2/- per share.

Every holder of the equity share of the Company is entitled to one vote per share held.

In the event of liquidation of the Company, the equity shareholders will be entitled to receive remaining assets of the Company after the distribution / repayment of all creditors. The distribution to the equity shareholders will be in proportion of the number of shares held by each shareholder.

The Company declares and pays dividend on the equity shares in Indian Rupees. Dividend proposed by the Board of Directors is subject to approval of the shareholders at the ensuing Annual General Meeting.

During the year ended 31st March, 2014 an amount of H 3.00 of dividend per equity share was proposed for the equity shareholders (P.Y H 2.50 per equity share).

 

E)      Shares in the company held by each shareholder holding more than 5 percent shares specifying the number of shares held:

 

Particulars

As on 31.03.2014

No. of Shares

% of Held

Alembic Limited

55000000

29.18%

Shreno Limited

18368780

9.74%

Sierra Investments Limited

17167670

9.11%

Whitefield Chemtech Limited

18285230

9.70%

Nirayu Private Limited

16213755

8.60%

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

377.032

377.032

377.032

(b) Reserves & Surplus

5919.928

4220.606

2385.064

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

6296.960

4597.638

2762.096

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

522.200

705.347

1284.837

(b) Deferred tax liabilities (Net)

227.170

138.969

53.746

(c) Other long term liabilities

127.038

127.607

118.417

(d) long-term provisions

66.806

60.606

51.016

Total Non-current Liabilities (3)

943.214

1032.529

1508.016

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

254.237

701.145

1462.768

(b) Trade payables

2818.996

2342.456

1317.541

(c) Other current liabilities

606.211

692.529

849.005

(d) Short-term provisions

704.845

620.550

259.085

Total Current Liabilities (4)

4384.289

4356.680

3888.399

 

 

 

 

TOTAL

11624.463

9986.847

8158.511

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

3969.606

3422.215

2719.854

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

206.692

322.618

265.030

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

333.284

33.542

33.542

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

416.417

358.788

65.447

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

4925.999

4137.163

3083.873

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

3107.782

2668.333

2192.319

(c) Trade receivables

2605.587

2323.830

2019.739

(d) Cash and cash equivalents

53.385

42.497

12.880

(e) Short-term loans and advances

931.710

795.024

849.700

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

6698.464

5829.684

5074.638

 

 

 

 

TOTAL

11624.463

9966.847

8158.511

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

18437.871

14926.383

13743.043

 

 

Other Income

31.927

39.320

14.207

 

 

TOTAL                                     (A)

18469.798

14965.703

13757.250

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

5559.293

4702.977

5282.376

 

 

Purchase of Finished Goods

1980.675

1655.905

1677.929

 

 

Changes in Inventories of Finished Goods and Work in Process

(406.484)

213.401

(644.398)

 

 

Employee Benefit Expenses

2444.594

1937.897

1684.582

 

 

Research & Development Expenses

1050.963

736.328

585.821

 

 

Other Expenses

4218.612

3242.227

3070.835

 

 

TOTAL                                     (B)

14847.653

12488.735

11657.145

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

3622.145

2476.968

2100.105

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

98.089

145.743

262.134

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

3524.056

2331.225

1837.971

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                     (F)

404.871

349.646

336.458

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

3119.185

1981.579

1501.513

 

 

 

 

 

Less

TAX                                                                  (H)

736.321

407.143

296.162

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

2382.864

1574.436

1205.351

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

759.307

536.257

216.803

 

 

 

 

 

 

APPROPRIATIONS

 

 

 

 

 

Debenture Redemption Reserve

0.000

0.000

79.160

 

 

Provision for Dividend - Equity Shares

565.548

471.290

263.922

 

 

Provision for Corporate Dividend tax

96.114

80.096

42.815

 

 

Transfer to General Reserve

1000.000

800.000

500.000

 

BALANCE CARRIED TO THE B/S

1480.509

759.307

536.257

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

7501.748

4650.158

4679.560

 

 

Royalty

217.909

152.168

116.044

 

TOTAL EARNINGS

7719.657

4802.326

4795.604

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

1764.920

1554.182

1863.148

 

 

Packing Material , Components and Spare parts

168.272

90.897

21.803

 

TOTAL IMPORTS

1933.192

1645.079

1884.951

 

 

 

 

 

 

Earnings Per Share (Rs.)

12.64

8.35

6.39

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

PAT / Total Income

(%)

12.90

10.52

8.76

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

16.92

13.28

10.93

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

28.14

20.62

19.10

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.50

0.43

0.54

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.12

0.31

0.99

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.53

1.34

1.31

 

 

 

 

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Share Capital

377.032

377.032

377.032

Reserves & Surplus

2385.064

4220.606

5919.928

Net worth

2762.096

4597.638

6296.960

 

 

 

 

long-term borrowings

1284.837

705.347

522.200

Short term borrowings

1462.768

701.145

254.237

Total borrowings

2747.605

1406.492

776.437

Debt/Equity ratio

0.995

0.306

0.123

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

13,743.043

14,926.383

18,437.871

 

 

8.610

23.525

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

13,743.043

14,926.383

18,437.871

Profit

1,205.351

1,574.436

2,382.864

 

8.77%

10.55%

12.92%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

UNSECURED LOANS:

 

Particulars

31.03.2014

Rs. In Millions

31.03.2013

Rs. In Millions

Long Term Borrowings

 

 

Deposits

 

 

Deposits from Shareholders

9.980

41.930

Deposits from Public

(Interest rate varying from 9% to 11% and maturity period is 12 / 24 / 36 months)

92.750

66.337

 

 

 

Short Term Borrowings

 

 

Others

(Varying Coupon repayable within 180 days with an option of roll over)

199.857

597.080

 

 

 

Total

302.587

705.347

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10323112

02/12/2011

780,000,000.00

DBS BANK LIMITED

UPPER GROUND FLOR, BIRLA TOWER,, 25 BARAKHAMBA ROAD, NEW DELHI - 110001, INDIA

B27859248

2

10296745

30/06/2011

2,420,000,000.00

BANK OF BARODA & OTHER BANKS

FIRST FLOOR, BANK OF BARODA BUILDING, R. C. DUTT ROAD, VADODARA, GUJARAT - 390007, INDIA

B16625071

 

 

OPERATIONS:

 

Subject Standalone revenues from operations were Rs.18437.900 Millions for the year ended 31st March, 2014 as compared to Rs.14926.200 Millions for the previous year.

 

The Standalone profit before Interest, Depreciation, Non- recurring Income and expenses and Taxes was Rs.3590.200 Millions for the year as compared to Rs.2437.600 Millions for the previous year.

 

During the year, the interest and financing cost was Rs.98.100 Millions as compared to Rs.145.700 Millions in previous year.

 

Subject has made Net Profit of Rs.2382.800 Millions on standalone basis for the year as compared to Rs.1574.500 Millions for the previous year.

 

 

UNAUDITED FINANCIAL RESULTS FOR THE PERIOD ENDED 30TH JUNE, 2014

 

Particulars

30th June 2014

(Unaudited)

PART- I

 

(a)   Net Sales / Income from Operations

 

Domestic

2784.000

Exports

2052.500

Total

4836.500

Less : Excise Duty

24.800

Net Sales / Income from Operations

4811.700

(b)   Other Operating Income

6.300

Total Income from Operations

4818.000

Expenses

 

(a)   Decrease/(increase) in stock in trade and work in progress

(267.700)

(b)   Consumption of Raw Materials & Packing Materials

1472.800

(c)   Purchase of traded goods

564.600

(d)   Employees' Cost

732.200

(e)   Marketing Expense

495.400

(e)   Research and Development Expense

275.400

(f)    Excise Duty

15.200

(g)   Other Expenditure

597.200

Total Expenses

3885.100

Profit from Operations before Other Income, Interest, Depreciation & Exceptional Items

932.900

Other Income

1.800

Profit/(Loss) from Ordinary Activities before Interest,

934.700

Depreciation, & Exceptional Items

107.100

Interest (Net)

5.600

CSR Expense

6.500

Net Profit / (Loss) from Ordinary Activities before Tax

815.500

Tax Expense

 

Less : Provision for Current Tax

171.400

Less /Add : Provision for Deferred Tax Liability/(Assets)

29.300

Net Profit / (Loss) from Ordinary Activities after Tax

614.800

Paid up Equity Share Capital

 

( Face value of share Rs. 2/- )

377.000

Reserves excluding Revaluation Reserve

--

Basic & Diluted EPS (Not Annualised)

 

Debt Equity Ratio

3.26

 

PART- II

 

Particulars of Shareholding

 

Public Shareholding

 

- Number of Shares

48777294

- Percentage of Shareholding

25.87

Promoters and Promoter Group Shareholding

 

- Fully Non - Encumbered

 

- Number of Shares

139738620

- Percentage of Shares (as a % of the total shareholding of promoter and promoter group)

100.00

- Percentage of Shares (as a % of the total share capital of the Company)

74.13

 

INVESTOR COMPLAINTS

30.06.2014

Pending at the beginning of the quarter

Nil

Received during the quarter

5

Disposed of during the quarter

5

Remaining unresolved at the end of the quarter

Nil

 

 

FIXED ASSETS:

 

·         Free Hold Land

·         Lease Hold Land

·         Buildings

·         Employees Quarters

·         Plant and Equipments

·         R and D Equipments

·         Furniture and Fixtures

·         Vehicles

·         Office Equipments

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.06

UK Pound

1

Rs.101.84

Euro

1

Rs.81.56

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Analysis Done by :

KRN

 

 

Report Prepared by :

NKT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

7

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

--

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

64

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.